KLEBCIL Drug Patent Profile
✉ Email this page to a colleague
When do Klebcil patents expire, and what generic alternatives are available?
Klebcil is a drug marketed by King Pharms and is included in one NDA.
The generic ingredient in KLEBCIL is kanamycin sulfate. There are five drug master file entries for this compound. Additional details are available on the kanamycin sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KLEBCIL?
- What are the global sales for KLEBCIL?
- What is Average Wholesale Price for KLEBCIL?
Summary for KLEBCIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 137 |
| DailyMed Link: | KLEBCIL at DailyMed |
US Patents and Regulatory Information for KLEBCIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| King Pharms | KLEBCIL | kanamycin sulfate | INJECTABLE;INJECTION | 062170-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| King Pharms | KLEBCIL | kanamycin sulfate | INJECTABLE;INJECTION | 062170-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| King Pharms | KLEBCIL | kanamycin sulfate | INJECTABLE;INJECTION | 062170-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
